Table 2. Intra- and post-operative data.
| Characteristics | S group | L group | P value |
|---|---|---|---|
| Duration of anesthesia, min | 108.0 (83.0–145.0) | 111.0 (85–152.0) | 0.568 |
| Intraoperative medication | |||
| Propofol, mg | 888.4 (759.0–1,212.5) | 1,032.6 (751.8–1,347.1) | 0.368 |
| Remifentanil, μg | 1,225.0 (1,015.3–1,463.3) | 1,022.4 (757.0–1,370.0) | 0.015 |
| Lidocaine, mg | 0.0 (0.0–0.0) | 340 (226.1–435.6) | 0.000 |
| Fluid balance | |||
| Total fluid infusion, mL | 1,079.5±365.7 | 1,128.2±360.8 | 0.467 |
| Estimated blood loss, mL | 58.5±21.1 | 51.7±19.5 | 0.143 |
| Duration of surgery, min | 128.0 (101.0–160.0) | 140.0 (96.0–186.5) | |
| Type of breast surgery | 0.810 | ||
| Mastectomy | 29 (70.7) | 28 (68.3) | |
| Lumpectomy | 12 (29.3) | 13 (31.7) | |
| Management of ALNs | 0.671 | ||
| Dissection of ALNs | 15 (36.6) | 18 (43.9) | |
| Sentinel node biopsy | 23 (56.1) | 19 (46.3) | |
| None | 3 (7.3) | 4 (9.8) | |
| Induction | |||
| HR, beats/min | 82.5±7.6 | 81.9±8.8 | 0.749 |
| MAP, mmHg | 93.5±12.4 | 89.7±10.7 | 0.138 |
| SPO2, % | 96.4±1.7 | 96.6±1.7 | 0.567 |
| Extubation | |||
| HR, beats/min | 95.9±6.4 | 93.3±6.7 | 0.086 |
| MAP, mmHg | 100.2±7.1 | 99.6±8.5 | 0.707 |
| SPO2, % | 98.2±1.4 | 97.9±1.3 | 0.354 |
| Time, min | 8.9±4.2 | 6.2±3.2 | 0.002 |
| Frequency of analgesics used within 24 h after surgery | 1 (0–2) | 0 (0–1) | 0.036 |
| Postoperative chemotherapy | 29 (70.7) | 27 (65.9) | 0.635 |
| Postoperative radiotherapy | 19 (46.3) | 17 (41.5) | 0.656 |
| Postoperative hormone therapy | 23 (56.1) | 22 (53.7) | 0.824 |
Data are median (interquartile range), number (%), or mean ± SD. S, control; L, lidocaine; ALNs, axillary lymph nodes; HR, heart rate; MAP, mean arterial pressure; SPO2, oxygen saturation; SD, standard deviation.